Work

Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema

Year: 2019

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4342

Authors: S. Idell, L.E.L. Beckert, B. Brockway, G. Simpson, A.M. Southcott, Y.C.G. Lee, N.M. Rahman, R.W. Light, S. Shoemaker, J.D. Gillies, A.A. Komissarov, G. Florova, K. Sarva

Institutions: The University of Texas Health Science Center at Tyler, University of Otago, Cairns Hospital, Footscray Hospital, Western Health, University of Oxford, Vanderbilt University

Language: English

Topic: Pleural and Pulmonary Diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2971179662

Cites:

Cited by:

Related to: 10